Brief Title : Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm
Launched by ASAN MEDICAL CENTER · Sep 16, 2013
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • colorectal laterally spreading tumor that is more than 20 mm in diameter
- • other elevated or flat colorectal neoplasm without stalk, that is more than 20 mm in diameter
- Exclusion Criteria:
- • colorectal neoplasms that are proven or suspected to be invaded more than submucosal invasion
- • colorectal neoplasms that have severe fibrosis beneath the target lesion
- • patient's refusal to participate this study
- • less than 18 years old
- • subjects who cannot consent voluntarily due to the communication difficulty
About Asan Medical Center
Asan Medical Center, located in Seoul, South Korea, is a leading healthcare institution renowned for its commitment to advanced medical research and patient care. With a focus on innovative clinical trials, the center aims to enhance healthcare outcomes through rigorous scientific investigation and collaboration. Asan Medical Center is equipped with state-of-the-art facilities and a multidisciplinary team of experts dedicated to exploring new therapeutic approaches across various medical fields. Its robust infrastructure supports a wide range of clinical studies, contributing significantly to the global medical community's understanding of diseases and treatment efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Jeong-Sik Byoen, MD
Principal Investigator
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials